A systematic capsid evolution approach performed in vivo for the design of AAV vectors with tailored properties and tropism.

barcoding dopamine gene therapy retrograde transport vector evolution

Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
26 Dec 2019
Historique:
pubmed: 11 12 2019
medline: 11 12 2019
entrez: 11 12 2019
Statut: ppublish

Résumé

Adeno-associated virus (AAV) capsid modification enables the generation of recombinant vectors with tailored properties and tropism. Most approaches to date depend on random screening, enrichment, and serendipity. The approach explored here, called BRAVE (barcoded rational AAV vector evolution), enables efficient selection of engineered capsid structures on a large scale using only a single screening round in vivo. The approach stands in contrast to previous methods that require multiple generations of enrichment. With the BRAVE approach, each virus particle displays a peptide, derived from a protein, of known function on the AAV capsid surface, and a unique molecular barcode in the packaged genome. The sequencing of RNA-expressed barcodes from a single-generation in vivo screen allows the mapping of putative binding sequences from hundreds of proteins simultaneously. Using the BRAVE approach and hidden Markov model-based clustering, we present 25 synthetic capsid variants with refined properties, such as retrograde axonal transport in specific subtypes of neurons, as shown for both rodent and human dopaminergic neurons.

Identifiants

pubmed: 31818949
pii: 1910061116
doi: 10.1073/pnas.1910061116
pmc: PMC6936499
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

27053-27062

Auteurs

Marcus Davidsson (M)

Molecular Neuromodulation, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden.

Gang Wang (G)

Molecular Neuromodulation, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden.

Patrick Aldrin-Kirk (P)

Molecular Neuromodulation, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden.

Tiago Cardoso (T)

Developmental and Regenerative Neurobiology, Department of Experimental Medical Science, Lund Stem Cell Center, Lund University, 221 84 Lund, Sweden.

Sara Nolbrant (S)

Developmental and Regenerative Neurobiology, Department of Experimental Medical Science, Lund Stem Cell Center, Lund University, 221 84 Lund, Sweden.

Morgan Hartnor (M)

Molecular Neuromodulation, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden.

Janitha Mudannayake (J)

Molecular Neuromodulation, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden.

Malin Parmar (M)

Developmental and Regenerative Neurobiology, Department of Experimental Medical Science, Lund Stem Cell Center, Lund University, 221 84 Lund, Sweden.

Tomas Björklund (T)

Molecular Neuromodulation, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden.

Classifications MeSH